[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Brain Tumor Drugs Global Market Report 2020. Including: 1) By Drugs: Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib 2) By End User: Hospital Pharmacies, Clinics, Others. Covering: Pfizer Inc., Shimadzu Corporation, Toshiba Medical Systems, Merck & Co. Inc., AstraZeneca

December 2019 | 200 pages | ID: B07397C0B302EN
The Business Research Company

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
If ordered it will be delivered within 3-5 business days.

Brain Tumor Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global brain tumor drugs market.

REASONS TO PURCHASE
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
DESCRIPTION:

Where is the largest and fastest growing market for the brain tumor drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Brain Tumor Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
SCOPE

Markets Covered: 1) By Drugs: Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib 2) By End User: Hospital Pharmacies, Clinics, Others

Companies Mentioned: Pfizer Inc., Shimadzu Corporation, Toshiba Medical Systems, Merck & Co. Inc., AstraZeneca

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. EXECUTIVE SUMMARY

2. BRAIN TUMOR DRUGS MARKET CHARACTERISTICS

3. BRAIN TUMOR DRUGS MARKET SIZE AND GROWTH

3.1. Global Brain Tumor Drugs Historic Market, 2015 - 2019, $ Billion
  3.1.1. Drivers Of The Market
  3.1.2. Restraints On The Market
3.2. Global Brain Tumor Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
  3.2.1. Drivers Of The Market
  3.2.2. Restraints On the Market

4. BRAIN TUMOR DRUGS MARKET SEGMENTATION

4.1. Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Temozolomide
Carmustine
Cisplatin
Bevacizumab
Geftinib
Erlotinib
4.2. Global Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Hospital Pharmacies
Clinics
Others

5. BRAIN TUMOR DRUGS MARKET REGIONAL AND COUNTRY ANALYSIS

5.1. Global Brain Tumor Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Brain Tumor Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. ASIA-PACIFIC BRAIN TUMOR DRUGS MARKET

6.1. Asia-Pacific Brain Tumor Drugs Market Overview
6.2. Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. CHINA BRAIN TUMOR DRUGS MARKET

7.1. China Brain Tumor Drugs Market Overview
7.2. China Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. INDIA BRAIN TUMOR DRUGS MARKET

8.1. India Brain Tumor Drugs Market Overview
8.2. India Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. JAPAN BRAIN TUMOR DRUGS MARKET

9.1. Japan Brain Tumor Drugs Market Overview
9.2. Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. AUSTRALIA BRAIN TUMOR DRUGS MARKET

10.1. Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. INDONESIA BRAIN TUMOR DRUGS MARKET

11.1. Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. SOUTH KOREA BRAIN TUMOR DRUGS MARKET

12.1. South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. WESTERN EUROPE BRAIN TUMOR DRUGS MARKET

13.1. Western Europe Brain Tumor Drugs Market Overview
13.2. Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK BRAIN TUMOR DRUGS MARKET

14.1. UK Brain Tumor Drugs Market Overview
14.2. UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. GERMANY BRAIN TUMOR DRUGS MARKET

15.1. Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. FRANCE BRAIN TUMOR DRUGS MARKET

16.4. France Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. EASTERN EUROPE BRAIN TUMOR DRUGS MARKET

17.1. Eastern Europe Brain Tumor Drugs Market Overview
17.2. Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. RUSSIA BRAIN TUMOR DRUGS MARKET

18.1. Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. NORTH AMERICA BRAIN TUMOR DRUGS MARKET

19.1. North America Brain Tumor Drugs Market Overview
19.2. North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA BRAIN TUMOR DRUGS MARKET

20.1. USA Brain Tumor Drugs Market Overview
20.2. USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. SOUTH AMERICA BRAIN TUMOR DRUGS MARKET

21.1. South America Brain Tumor Drugs Market Overview
21.2. South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. BRAZIL BRAIN TUMOR DRUGS MARKET

22.1. Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. MIDDLE EAST BRAIN TUMOR DRUGS MARKET

23.1. Middle East Brain Tumor Drugs Market Overview
23.2. Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. AFRICA BRAIN TUMOR DRUGS MARKET

24.1. Africa Brain Tumor Drugs Market Overview
24.2. Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. BRAIN TUMOR DRUGS MARKET COMPETITIVE LANDSCAPE AND COMPANY PROFILES

25.1. Brain Tumor Drugs Market Competitive Landscape
25.2. Brain Tumor Drugs Market Company Profiles
  25.2.1. Pfizer Inc.
    25.2.1.1. Overview
    25.2.1.2. Products and Services
    25.2.1.3. Strategy
    25.2.1.4. Financial Performance
  25.2.2. Shimadzu Corporation
    25.2.2.1. Overview
    25.2.2.2. Products and Services
    25.2.2.3. Strategy
    25.2.2.4. Financial Performance
  25.2.3. Toshiba Medical Systems
    25.2.3.1. Overview
    25.2.3.2. Products and Services
    25.2.3.3. Strategy
    25.2.3.4. Financial Performance
  25.2.4. Merck & Co. Inc.
    25.2.4.1. Overview
    25.2.4.2. Products and Services
    25.2.4.3. Strategy
    25.2.4.4. Financial Performance
  25.2.5. AstraZeneca
    25.2.5.1. Overview
    25.2.5.2. Products and Services
    25.2.5.3. Strategy
    25.2.5.4. Financial Performance

26. KEY MERGERS AND ACQUISITIONS IN THE BRAIN TUMOR DRUGS MARKET

27. BRAIN TUMOR DRUGS MARKET TRENDS AND STRATEGIES

28. PRODUCT PIPELINE ANALYSIS

29. BRAIN TUMOR DRUGS MARKET FUTURE OUTLOOK AND POTENTIAL ANALYSIS

30. APPENDIX

30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer


More Publications